Clinical outcomes and predictors for ESRD and mortality in primary GN.
Abstract | BACKGROUND AND OBJECTIVES: Relatively little is known about the long-term outcomes of different histologic types of primary glomerulonephritis in Asian populations. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: RESULTS: CONCLUSIONS: Most predictors for ESRD and overall mortality found in this ethnic Chinese cohort were similar to other studies. However, some risk factors linked with distinct glomerular pathologies displayed differential clinical outcomes.
|
Authors | Yu-Hsiang Chou, Yu-Chung Lien, Fu-Chang Hu, Wei-Chou Lin, Chih-Chin Kao, Chun-Fu Lai, Wen-Chih Chiang, Shuei-Liong Lin, Tun-Jun Tsai, Kwan-Dun Wu, Yung-Ming Chen |
Journal | Clinical journal of the American Society of Nephrology : CJASN
(Clin J Am Soc Nephrol)
Vol. 7
Issue 9
Pg. 1401-8
(Sep 2012)
ISSN: 1555-905X [Electronic] United States |
PMID | 22798538
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Adult
- Aged
- Asian People
- Biomarkers
(blood)
- Biopsy
- Chi-Square Distribution
- Disease Progression
- Female
- Glomerulonephritis
(blood, ethnology, mortality, pathology, therapy)
- Glomerulonephritis, IGA
(mortality, pathology)
- Glomerulonephritis, Membranous
(mortality, pathology)
- Glomerulosclerosis, Focal Segmental
(mortality, pathology)
- Hemoglobins
(metabolism)
- Humans
- Incidence
- Kaplan-Meier Estimate
- Kidney
(pathology)
- Kidney Failure, Chronic
(blood, ethnology, mortality, pathology, therapy)
- Male
- Middle Aged
- Multivariate Analysis
- Nephrosis, Lipoid
(mortality, pathology)
- Prognosis
- Proportional Hazards Models
- Proteinuria
(mortality)
- Renal Dialysis
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Sex Factors
- Taiwan
(epidemiology)
- Time Factors
- Young Adult
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|